Assessment of Modifiable Factors for the Association of Marital Status With Cancer-Specific Survival
Zihang Chen(Sun Yat-sen University), Lin Li(Harbin Veterinary Research Institute), Xiaojing Du(Sun Yat-sen University), Guang‐Li Zhu(Sun Yat-sen University), Guan‐Qun Zhou(Sun Yat-sen University), Ying Sun(Qilu Hospital of Shandong University), Dan‐Wan Wen(Sun Yat-sen University), Cheng Xu(Pennsylvania State University), Lei Chen(Cincinnati Children's Hospital Medical Center), Qing Liu(Cardiovascular Institute of the South), Jun Ma(Shanghai Jiao Tong University), Jia‐Wei Lv(Zhejiang Chinese Medical University), Yuan-Zhe Zhang(Sun Yat-sen University), Chen‐Fei Wu(Sun Yat-sen University), Kai‐Bin Yang(Sun Yat-sen University Cancer Center)
Cited by 93
Related Papers
Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study
|The Lancet Oncology|2011|4.1k
Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma
|New England Journal of Medicine|2019|934
The Lysosomal v-ATPase-Ragulator Complex Is a Common Activator for AMPK and mTORC1, Acting as a Switch between Catabolism and Anabolism
|Cell Metabolism|2014|545